Prostate-specific antigen serum screening has led to an increase of prostate needle biopsies in the last two decades, which in turn increased the rate of difficult diagnostic situations (small carcinoma infiltrates vs benign mimickers of carcinoma) where immunohistochemical tests are necessary. The gene discussed is KLK3; the disease is carcinoma.